Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease.

× No keyword cloud information.

31 in total

Review 1. Addressing cardiovascular risk beyond low-density lipoprotein cholesterol: the high-density lipoprotein cholesterol story.

Authors: Emma A Meagher
Journal: Curr Cardiol Rep Date: 2004-11 Impact factor: 2.931

2. Origins of intestinal ABCA1-mediated HDL-cholesterol.

Authors: F Jeffrey Field; Kim Watt; Satya N Mathur
Journal: J Lipid Res Date: 2008-08-18 Impact factor: 5.922

3. Oxidative mechanisms and atherothrombotic cardiovascular disease.

Authors: Jane A Leopold; Joseph Loscalzo
Journal: Drug Discov Today Ther Strateg Date: 2008-03

4. Recalculation of 23 mouse HDL QTL datasets improves accuracy and allows for better candidate gene analysis.

Authors: Cheryl Ackert-Bicknell; Beverly Paigen; Ron Korstanje
Journal: J Lipid Res Date: 2013-02-07 Impact factor: 5.922

Review 5. Identifying novel genes for atherosclerosis through mouse-human comparative genetics.

Authors: Xiaosong Wang; Naoki Ishimori; Ron Korstanje; Jarod Rollins; Beverly Paigen
Journal: Am J Hum Genet Date: 2005-05-19 Impact factor: 11.025

Review 6. CETP Inhibition: does the future look promising?

Authors: Peter P Toth
Journal: Curr Cardiol Rep Date: 2011-12 Impact factor: 2.931

7. Remodeling pattern is related to the degree of coronary plaque regression induced by pitavastatin: a sub-analysis of the TOGETHAR trial with intravascular ultrasound and coronary angioscopy.

Authors: Tadateru Takayama; Takafumi Hiro; Yasunori Ueda; Satoshi Saito; Kazuhisa Kodama; Sei Komatsu; Atsushi Hirayama
Journal: Heart Vessels Date: 2014-01-25 Impact factor: 2.037

Review 8. High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy.

Authors: S-H Wang; S-G Yuan; D-Q Peng; S-P Zhao
Journal: Clin Exp Immunol Date: 2010-01-06 Impact factor: 4.330

Review 9. Lipid-lowering agents that cause drug-induced hepatotoxicity.

Authors: Sidharth S Bhardwaj; Naga Chalasani
Journal: Clin Liver Dis Date: 2007-08 Impact factor: 6.126

Review 10. Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.

Authors: M John Chapman; Wilfried Le Goff; Maryse Guerin; Anatol Kontush
Journal: Eur Heart J Date: 2009-10-12 Impact factor: 29.983